Optimizing Screen Failures in Clinical Trials
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
One of the most critical components of all experiences is the ending. Disney World is one of those...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
Clinical research is complex, and rightfully so. What we do is often uncharted and difficult....
GxP compliance is becoming increasingly critical for a patient recruitment capability, and for good...
Choosing the right technology to engage clinical trial sites is crucial for study success. Two...
In a recent interview with Brad Hightower and Denali Rose on the Note to File podcast, our CEO,...
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
If you missed DPharm 2024, you also missed watching a live matchmaking event with Nichole Gallatti,...
In a throwback to a podcast with Joseph Kim, Chief Strategy Officer at ProofPilot, Brad Hightower,...
Over 50% of all FDA warning letters are attributed to non-compliance by the investigator or clinic...